Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF
This study compared the effectiveness and safety of reduced-dose dabigatran, reduced-dose rivaroxaban, and warfarin in individuals aged 85 and older with atrial fibrillation.Journal of the American Geriatrics Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
More News: Atrial Fibrillation | Cardiology | Coumadin | Geriatrics | Health | Heart | Pradaxa | Study | Warfarin